These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32659385)

  • 1. Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients.
    Lamoth F; Glampedakis E; Boillat-Blanco N; Oddo M; Pagani JL
    Clin Microbiol Infect; 2020 Dec; 26(12):1706-1708. PubMed ID: 32659385
    [No Abstract]   [Full Text] [Related]  

  • 2. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
    Fekkar A; Neofytos D; Nguyen MH; Clancy CJ; Kontoyiannis DP; Lamoth F
    Clin Microbiol Infect; 2021 Sep; 27(9):1376-1378. PubMed ID: 34192575
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Mitaka H; Kuno T; Takagi H; Patrawalla P
    Mycoses; 2021 Sep; 64(9):993-1001. PubMed ID: 33896063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort.
    Versyck M; Zarrougui W; Lambiotte F; Elbeki N; Saint-Leger P
    J Mycol Med; 2021 Jun; 31(2):101122. PubMed ID: 33621792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Aspergillosis associated with Covid-19: A word of caution.
    Gouzien L; Cocherie T; Eloy O; Legriel S; Bedos JP; Simon C; Marque-Juillet S; Ferré A; Bruneel F
    Infect Dis Now; 2021 Jun; 51(4):383-386. PubMed ID: 33490993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.
    Alanio A; Dellière S; Fodil S; Bretagne S; Mégarbane B
    Lancet Respir Med; 2020 Jun; 8(6):e48-e49. PubMed ID: 32445626
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspergillosis in Critically Ill Patients with and Without COVID-19 in a Tertiary Hospital in Southern Brazil.
    Trápaga MR; Poester VR; Basso RP; Blan BDS; Munhoz LS; Pasqualotto AC; Werner TDF; Figurelli ML; Stevens DA; von Groll A; Xavier MO
    Mycopathologia; 2024 Jun; 189(3):48. PubMed ID: 38847987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches.
    Jenks JD; Nam HH; Hoenigl M
    Mycoses; 2021 Sep; 64(9):1002-1014. PubMed ID: 33760284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis.
    Singh S; Verma N; Kanaujia R; Chakrabarti A; Rudramurthy SM
    Mycoses; 2021 Sep; 64(9):1015-1027. PubMed ID: 34057252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19).
    Dupont D; Menotti J; Turc J; Miossec C; Wallet F; Richard JC; Argaud L; Paulus S; Wallon M; Ader F; Persat F
    Med Mycol; 2021 Jan; 59(1):110-114. PubMed ID: 32914189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of co-infection and secondary infection amongst critically ill COVID-19 patients in the first two waves of the pandemic.
    De Corte T; Kohler K; Cecconi M; De Waele JJ; Conway Morris A;
    Intensive Care Med; 2024 Jun; 50(6):989-993. PubMed ID: 38709296
    [No Abstract]   [Full Text] [Related]  

  • 13. Invasive pulmonary aspergillosis and candidiasis in a critically ill patient with COVID-19.
    Benedetti MF; de Abreu MS; Cadena RC; Arias MC; Posse G; Capece P; Nusblat A; Cuestas ML
    J Mycol Med; 2022 May; 32(2):101251. PubMed ID: 35123158
    [No Abstract]   [Full Text] [Related]  

  • 14. Invasive pulmonary aspergillosis in critically ill patients with COVID-19 in Australia: implications for screening and treatment.
    Tio SY; Williams E; Worth LJ; Deane AM; Bond K; Slavin MA; Sasadeusz J
    Intern Med J; 2021 Dec; 51(12):2129-2132. PubMed ID: 34939293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
    Ezeokoli OT; Pohl CH
    S Afr Med J; 2020 Oct; 110(11):1081-1085. PubMed ID: 33403982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of critically ill patients infected with COVID-19 in Abu Dhabi, United Arab Emirates.
    Abdallah K; Hamed F; Rahman N; Salam S; Mallat J
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):483-485. PubMed ID: 32660852
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of ICU criteria for diagnosis of invasive pulmonary aspergillosis in nonhematologic critically ill patients.
    Lee SI; Sung H; Hong SB; Lim CM; Koh Y; Huh JW
    Med Mycol; 2020 Apr; 58(3):275-281. PubMed ID: 31204780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Invasive fungal infections in ICU patients - What's New?].
    Kochanek M; Köhler P
    Dtsch Med Wochenschr; 2021 Apr; 146(7):455-460. PubMed ID: 33780991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in invasive pulmonary aspergillosis in the critically ill.
    Koulenti D; Vogelaers D; Blot S
    Intensive Care Med; 2014 May; 40(5):723-6. PubMed ID: 24647810
    [No Abstract]   [Full Text] [Related]  

  • 20. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
    Schauwvlieghe AFAD; Rijnders BJA; Philips N; Verwijs R; Vanderbeke L; Van Tienen C; Lagrou K; Verweij PE; Van de Veerdonk FL; Gommers D; Spronk P; Bergmans DCJJ; Hoedemaekers A; Andrinopoulou ER; van den Berg CHSB; Juffermans NP; Hodiamont CJ; Vonk AG; Depuydt P; Boelens J; Wauters J;
    Lancet Respir Med; 2018 Oct; 6(10):782-792. PubMed ID: 30076119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.